2024 annual financial data
Coherus Oncology 2024 Operating margin
Coherus Oncology 2024 operating margin with verified reported values.
Direct answer
Operating margin was -41.83%.
Operating income was -111,667,000 USD and net income was 28,507,000 USD.
Operating cash flow was -20,440,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 266,960,000 USD
- Operating income
- -111,667,000 USD
- Net income
- 28,507,000 USD
- Operating cash flow
- -20,440,000 USD